AMIR HAJRASOULIHA, MD
Retina Specialist (Ophthalmology) Physician in INDIANAPOLIS, Indiana. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
AMIR HAJRASOULIHA, MD filed 217 Medicare Part D claims in 2023 as a Retina Specialist (Ophthalmology) Physician in INDIANAPOLIS, Indiana, prescribing 75% generic.
- 217
- Part D claims, 2023
- 75%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
AMIR HAJRASOULIHA, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
217 49th percentile higher than 49% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
AMIR HAJRASOULIHA, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about AMIR HAJRASOULIHA, MD?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Indiana
How Retina Specialist (Ophthalmology) Physician compares to other specialties among Indiana providers
Retina Specialist (Ophthalmology) Physician share within Indiana
Retina Specialist (Ophthalmology) Physician is one of the more visible NUCC categories in Indiana
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Retina Specialist (Ophthalmology) Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Retina Specialist (Ophthalmology) Physician ABMS/AOA estimate
Est. board-certified rate (Retina Specialist (Ophthalmology) Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Retina Specialist (Ophthalmology) Physician US NPIs
Specialty board-certified rate — Retina Specialist (Ophthalmology) Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
AMIR HAJRASOULIHA, MD appears in the CMS NPPES registry as a Retina Specialist (Ophthalmology) Physician provider holding MD credentials at 1160 W MICHIGAN ST, INDIANAPOLIS, IN, 46202, with a listed phone of (317) 944-2020. NPI 1083916027 was issued on 11/24/2010. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what HAJRASOULIHA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 217 prescription claims written by this provider, covering 63 Medicare beneficiaries and totaling roughly $10K in drug spend, split 25% brand-name and 75% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Retina Specialist (Ophthalmology) Physician is a narrow specialty nationwide, with 913 enrolled providers across 48 states and an average of 558 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1083916027 |
|---|---|
| Specialty | Retina Specialist (Ophthalmology) Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 11/24/2010 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm AMIR HAJRASOULIHA, MD's current license status, disciplinary history, and board certifications with the Indiana Medical Licensing Board in Indiana before relying on this page for a clinical or care decision.
How we sourced this profile
Hospital and facility affiliations
Facilities where AMIR HAJRASOULIHA, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for AMIR HAJRASOULIHA, MD. Source: openpaymentsdata.cms.gov.
Total received
$123
Largest payer
Carl Zeiss Meditec USA, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
25% brand-name claims vs 75% generic, on 217 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 363
- Total Day Supply
- 10,137
- Brand vs Generic
- 25% brand / 75% generic
- Brand Drug Cost
- $3K
- Generic Drug Cost
- $7K
Patient Demographics
- Average Patient Age
- 70.7 years
- Avg HCC Risk Score
- 2.17
- Gender Split
- 62% female / 38% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What AMIR HAJRASOULIHA, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Prednisolone Acetate
Prednisolone Acetate
43 claims
- Latanoprost
Latanoprost
42 claims
- Dorzolamide-Timolol
Dorzolamide-Timolol
27 claims
- Brimonidine Tartrate
Brimonidine Tartrate
20 claims
- Moxifloxacin
Moxifloxacin
20 claims
- Timolol Maleate 14
Timolol Maleate
14 claims
- Difluprednate 11
Difluprednate
11 claims
| Drug | Claims |
|---|---|
| Prednisolone Acetate | 43 |
| Latanoprost | 42 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 27 |
| Brimonidine Tartrate | 20 |
| Moxifloxacin Moxifloxacin Hcl | 20 |
| Timolol Maleate | 14 |
| Difluprednate | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Retina Specialist (Ophthalmology) Physician Overview
How AMIR HAJRASOULIHA, MD fits within the Retina Specialist (Ophthalmology) Physician landscape nationally.
AMIR HAJRASOULIHA, MD's 217 claims are below the specialty average of 558.
Nearby Retina Specialist (Ophthalmology) Physician Providers in Indiana
Other clinicians with the same primary specialty enrolled in Indiana, drawn from the same CMS NPPES roster as HAJRASOULIHA.
Compare Retina Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Indiana
Frequently Asked Questions
What is AMIR HAJRASOULIHA, MD's specialty? ▼
How much does AMIR HAJRASOULIHA, MD prescribe under Medicare Part D? ▼
Where is AMIR HAJRASOULIHA, MD located? ▼
What is AMIR HAJRASOULIHA, MD's NPI number? ▼
Does AMIR HAJRASOULIHA, MD prescribe more brand-name or generic drugs? ▼
How many Retina Specialist (Ophthalmology) Physician providers are there in the US? ▼
What drugs does AMIR HAJRASOULIHA, MD prescribe most often? ▼
Does AMIR HAJRASOULIHA, MD accept Medicare? ▼
How can I verify AMIR HAJRASOULIHA, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology